Kazia Therapeutics (KZIA) News Today $4.96 -0.04 (-0.80%) (As of 11:38 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Kazia Therapeutics Secures Nasdaq ComplianceNovember 13, 2024 | markets.businessinsider.comKazia Therapeutics Advances Paxalisib with FDA MeetingNovember 4, 2024 | markets.businessinsider.comKazia Therapeutics announces granting of Type C meeting with FDANovember 4, 2024 | markets.businessinsider.comKazia Therapeutics Announces Granting of Type C Meeting with FDA to Discuss Potential Next Steps for Paxalisib in the Treatment of Newly Diagnosed Glioblastoma MultiformeNovember 4, 2024 | prnewswire.comKazia Therapeutics trading halted, news pendingOctober 26, 2024 | markets.businessinsider.comKazia Therapeutics Adjusts ADS Ratio to Boost Nasdaq ListingOctober 16, 2024 | finance.yahoo.comKazia Therapeutics (NASDAQ:KZIA) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comKazia Announces Positive Phase 1 Data For Concurrent Paxalisib, Radiation Therapy In Brain TumorOctober 3, 2024 | markets.businessinsider.comKazia Therapeutics Announces Presentation of Promising Phase I Data Evaluating Concurrent Paxalisib and Radiation Therapy in Patients with Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations at the American Society for Radiation Oncology 66th Annual MeetingOctober 2, 2024 | prnewswire.comKazia Therapeutics Announces Presentation of EVT801 Clinical Data at 15th Biennial Ovarian Cancer Research SymposiumSeptember 23, 2024 | prnewswire.comKAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFERSeptember 12, 2024 | prnewswire.comKazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?July 31, 2024 | investorplace.comBiotech Stock Laboratory: Try a Small Experiment With Kazia TherapeuticsJuly 25, 2024 | investorplace.comFrom Pennies to Dollars: 3 Sub-$5 Stocks Set to Explode HigherJuly 12, 2024 | investorplace.comKZIA Stock Alert: Kazia Continues Its Surge on Thursday With 51% GainsJuly 11, 2024 | investorplace.comWhy Is Kazia Therapeutics (KZIA) Stock Up 300% Today?July 10, 2024 | investorplace.comKazia Therapeutics Announces Phase II/III Clinical Trial Results for Paxalisib in GlioblastomaJuly 10, 2024 | prnewswire.comKAZIA ANNOUNCES UPCOMING DIPG DATA PRESENTATIONS AT ISPNO AND PUBLICATION IN EUROPEAN JOURNAL OF CANCERJune 27, 2024 | prnewswire.comKazia Therapeutics Limited: Kazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price RequirementMay 24, 2024 | finanznachrichten.deKazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price RequirementMay 23, 2024 | prnewswire.comKAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTSMay 1, 2024 | prnewswire.comKazia Therapeutics Ltd ADR KZIAMarch 20, 2024 | morningstar.comKZIA Apr 2024 2.500 callMarch 16, 2024 | finance.yahoo.comKazia announces presentation of new data at AACR Annual MeetingMarch 13, 2024 | prnewswire.comWhat's Going With Australia-Based Cancer Firm Kazia Therapeutics On Wednesday?February 21, 2024 | msn.comKazia Therapeutics Limited: Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary EndpointFebruary 21, 2024 | finanznachrichten.deKazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary EndpointFebruary 21, 2024 | finance.yahoo.comKazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary EndpointFebruary 21, 2024 | prnewswire.comKazia Therapeutics LimitedFebruary 19, 2024 | thestreet.comKazia Therapeutics Ltd. ADRFebruary 14, 2024 | wsj.comViking Therapeutics, Inc. Common Stock (VKTX)February 13, 2024 | nasdaq.comKAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTSJanuary 18, 2024 | finance.yahoo.comKazia Therapeutics files to sell 591,697 ADSs for holdersDecember 15, 2023 | msn.comKazia Therapeutics Announces Closing of $2 Million Registered Direct OfferingDecember 5, 2023 | finance.yahoo.comKazia Therapeutics Shares Tumble on $2 Million Direct OfferingDecember 1, 2023 | marketwatch.comKazia Therapeutics Announces Registered Direct Offering - Quick FactsDecember 1, 2023 | markets.businessinsider.comKazia Therapeutics Announces $2 Million Registered Direct OfferingDecember 1, 2023 | finance.yahoo.comKazia Therapeutics Enters Non-binding LOI For Paxalisib Rights Outside Of OncologyNovember 29, 2023 | markets.businessinsider.comKazia stock jumps after proposed license deal for paxalisib outside oncologyNovember 29, 2023 | msn.comKazia Therapeutics Signs Letter of Intent for Paxalisib Development, CommercializationNovember 29, 2023 | marketwatch.comKAZIA ANNOUNCES NON-BINDING LETTER OF INTENT FOR THE PROPOSED GRANTING OF RIGHTS TO DEVELOP AND COMMERCIALIZE PAXALISIB OUTSIDE OF ONCOLOGYNovember 29, 2023 | finance.yahoo.comKAZIA PROVIDES OVERVIEW OF PAXALISIB RELATED PRESENTATIONS FROM THE SOCIETY OF NEURO-ONCOLOGY 2023 ANNUAL MEETINGNovember 21, 2023 | finance.yahoo.comKazia Therapeutics gets deficiency notice from NasdaqNovember 20, 2023 | msn.comKazia Therapeutics Limited's (NASDAQ:KZIA) large institutional owners must be happy as stock continues to impress, up 28% over the past weekNovember 18, 2023 | finance.yahoo.comKAZIA ANNOUNCES THE RELEASE OF PNOC022 CLINICAL STUDY ABSTRACT HIGHLIGHTING PAXALISIB IN DIFFUSE MIDLINE GLIOMA PATIENTS AHEAD OF THE SOCIETY OF NEURO-ONCOLOGY 2023 ANNUAL MEETINGNovember 15, 2023 | finance.yahoo.comKazia Provides Preliminary Update From Phase 2 Study Of Paxalisib In Primary CNS Lymphoma; Stock UpNovember 1, 2023 | markets.businessinsider.comKazia issues update on paxalisib study in CNS lymphoma patientsNovember 1, 2023 | msn.comKAZIA THERAPEUTICS PROVIDES PRELIMINARY UPDATE FROM ONGOING PHASE 2 STUDY OF PAXALISIB IN PRIMARY CNS LYMPHOMANovember 1, 2023 | finance.yahoo.comKAZIA THERAPEUTICS ANNOUNCES CLINICAL DATA AT ESMO 2023 FROM ONGOING PHASE 1 EVT801 STUDYOctober 23, 2023 | finance.yahoo.comTrading was temporarily halted for "KZIA" at 07:10 PM with a stated reason of "News pending."October 6, 2023 | marketbeat.com Get Kazia Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KZIA and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin KZIA Media Mentions By Week KZIA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KZIA News Sentiment▼-0.110.87▲Average Medical News Sentiment KZIA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KZIA Articles This Week▼20▲KZIA Articles Average Week Get Kazia Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KZIA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SCYX News STTK News SNTI News OTLK News VTVT News DYAI News RLYB News ACAB News CALC News VIRI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KZIA) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kazia Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Kazia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KZIA Stock Alerts